Welcome to The Ammon-Pinizzotto Center for Women’s Mental Health at MGH. Our Center, established in 1989, has been renamed following the generous gift from Carol Ammon and Dr. Marie Pinizzotto. These resources will be used to realize the overarching mission of the Center.
This website provides a range of current information including discussion of new research findings in women’s mental health and how such investigations inform day-to-day clinical practice. Despite the growing number of studies being conducted in women’s health, the clinical implications of such work are frequently controversial, leaving patients with questions regarding the most appropriate path to follow. Providing these resources to patients and their doctors so that individual clinical decisions can be made in a thoughtful and collaborative fashion dovetails with the mission of our Center.
All pregnant women between the ages of 18-45 with a history of psychiatric illness are eligible to enroll in the registry. The primary goal of this Registry is to determine the frequency of major malformations, such as heart defects, cleft lip, or neural tube defects, in infants exposed to atypical antipsychotics and antidepressants during pregnancy. We are currently seeking both controls and those being treated with atypical antipsychotics and/ or antidepressants. For more information, please visit this page, call 1-866-961-2388 or e-mail firstname.lastname@example.org.
Course of ADHD in Pregnancy and the Postpartum
If you are less than 20 weeks pregnant and have a history of ADHD, you may be eligible to take part in an observational research study for women maintaining, decreasing, or discontinuing psychostimulants during pregnancy and the postpartum. Women who participate will have 6 study visits that can be completed in-person at Massachusetts General Hospital or over the phone.
For more information, please call (617)726-2912 or email the study coordinator at email@example.com
Are you pregnant or planning a pregnancy? Do you feel depressed or have a history of depression? If you are less than 28 weeks pregnant or trying to conceive and have experienced depression now or in the past, you may be eligible to take part in a research study for the treatment of depression with a prenatal supplement. For more information, please visit this page, call Taylor at 617-643-9284 or email firstname.lastname@example.org
Are you pregnant or planning to become pregnant? Do you have a history of depression? Do you want to lose weight or have a healthier lifestyle? You may be eligible to participate in a research study evaluating a new lifestyle intervention for weight loss. Participants will receive 10 sessions of therapy at no cost to you.
If you are interested in participating or would like additional information, please call Samantha at 617-643-2076.
The MGH Center for Women’s Mental Health
Perinatal and Reproductive Psychiatry Program
Simches Research Building
185 Cambridge St Suite 2200
Boston, MA 02114
To make an appointment:
Massachusetts General Hospital Clinical Program: (617) 724-7792
Location of appointments:
Wang Ambulatory Care Center, Massachusetts General Hospital
15 Parkman St., Floor 8
Boston, MA 02114-3117
February 21, 2018
Because folate deficiency in pregnant women has been associated with an increased risk of neural tube defects, including anencephaly and spina bifida, it is recommended that all women take folic acid supplements during pregnancy. In addition, the Food and Drug Administration (FDA) has required (since 1998) the addition of folic acid to many enriched breads ...Read more
February 17, 2018
In two studies, researchers demonstrated that maternal depression during pregnancy is associated with worse child outcomes: more health problems in infants (Coburn et al 2018) and increased anxiety and depressive symptoms in older children (Glynn et al 2018). Also of interest are the next two articles which indicate that depressive symptoms within the first day ...Read more
February 14, 2018
The American College of Obstetricians and Gynecologists (ACOG) now recommends screening for perinatal depression, stating that “clinicians screen patients at least once during the perinatal period for depression and anxiety symptoms using a standard, validated tool.” Having the backing of ACOG is certainly a big step in the right direction. But as we move toward ...Read more
February 13, 2018
Sexual dysfunction is common among peri- and postmenopausal women and include a spectrum of problems, including low (or hypoactive) sexual desire, decreased satisfaction, and discomfort. Reports indicate that the prevalence of hypoactive sexual desire ranges from 9% in naturally postmenopausal women up to 26% in younger surgically postmenopausal women. A recent study compares the impact ...Read more
February 12, 2018
According to a recent national survey, 52% of adults in the United States reported using at least one dietary supplement. Among the most popular are vitamin and mineral supplements, which are taken by 48% and 39% of adults, respectively. It will undoubtedly surprise many that, despite the prevalent use of these supplements, most people do ...Read more
February 10, 2018
The article that grabbed my attention is the one at the top of the list, from May and colleagues, which suggests that fetal alcohol spectrum disorders (FASD) are probably more common than we had previously estimated. Using a conservative method of estimation, the prevalence of FASD among first-graders in 4 US communities ranged from 1.1% ...Read more